Top Premarket Decliners Syros Pharmaceuticals (SYRS) shares slumped 64% pre-bell Tuesday after the company said it will stop enrolling new patients in its phase 2 trial of a treatment candidate for ...
Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments